Asensus Surgical Inc (ASXC)

[TheWallStreetPoet]

Titan will have to dilute to the tune of 200 million before bringing a product to market in 18 months, e.g., many rounds of stock offerings and private placements with warrants w/ the eventual reverse split to gain access to a major exchange.

What would a sane rational mind do......buy a penny stock that won't make a dime for two years (if their lucky) or buy a stock with major funds and institutional investment on a major exchange with revenue likely next quarter?

The "surgibot" will have little trouble passing grade, whereas, the "titan" will have mountains to overcome. Moreover, ALF-X has already established and achieved approval in Europe.